Table 1 Characteristics of the included patients (n = 49).

From: Influence of bevacizumab therapy and intraretinal hemorrhage in long-term outcomes of hemorrhagic retinal arterial macroaneurysm

Characteristics

Age, years

78.0 ± 8.2

Male:female

12 (24.5%):37 (75.5%)

Diabetes mellitus

3 (6.1%)

Hypertension

33 (67.3%)

Use of anticoagulants

12 (24.5%)

Blood pressure, mmHg

Systolic

139.0 ± 15.7

Diastolic

76.1 ± 11.4

Extent of hemorrhage, disc areas

9.0 ± 5.2

Intraretinal hemorrhagea

Presence

19 (38.8%)

Absence

27 (55.1%)

Undeterminable

3 (6.1%)

Submacular hemorrhage

Presence

28 (57.1%)

Absence

21 (42.9%)

Treatment

Intravitreal bevacizumab

33 (67.3%)

Observation

16 (32.7%)

  1. Data are presented as mean ± standard deviation or number (%) where applicable.
  2. aIntraretinal hemorrhage is noted when it involves the fovea.